These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3096127)

  • 1. Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents.
    Collen D; Stump DC; Van de Werf F
    Am Heart J; 1986 Nov; 112(5):1083-4. PubMed ID: 3096127
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
    Collen D; Van de Werf F
    Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coronary thrombolysis in patients with acute myocardial infarction].
    Kambara H; Fudo T; Ono S
    Kokyu To Junkan; 1992 Jun; 40(6):537-47. PubMed ID: 1620990
    [No Abstract]   [Full Text] [Related]  

  • 4. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic treatment in acute myocardial infarction.
    Acar J; Vahanian A; Michel PL; Slama M; Cormier B; Roger V
    Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
    Sherry S
    Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
    [No Abstract]   [Full Text] [Related]  

  • 8. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
    Verstraete M
    Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
    Czyrski J
    Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of acute myocardial infarction in the 1990s.
    Flores ED; Lange RA; Cigarroa RG; Hillis LD
    Am J Med Sci; 1990 Jun; 299(6):415-24. PubMed ID: 2113353
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic therapy.
    Collen D; Lijnen HR
    Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy in acute myocardial infarct].
    Bode C; Baumann H; von Hodenberg E; Kübler W
    Med Klin (Munich); 1992 Feb; 87(2):64-9. PubMed ID: 1542285
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Potentials and pitfalls.
    Jaffe AS; Sobel BE
    JAMA; 1986 Jan; 255(2):237-9. PubMed ID: 3079842
    [No Abstract]   [Full Text] [Related]  

  • 14. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 15. Innovative approaches to plasminogen activator therapy.
    Haber E; Quertermous T; Matsueda GR; Runge MS
    Science; 1989 Jan; 243(4887):51-6. PubMed ID: 2492113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of intravenous thrombolytic therapy with pro-urokinase in acute myocardial infarction.
    Bode C; Schuler G; Schwarz F; Zimmermann R; Horn A; Kuebler W
    Am J Cardiol; 1987 Aug; 60(4):371. PubMed ID: 3113225
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolving concepts in the treatment of acute myocardial infarction.
    Lange RA; Hillis LD
    Am J Med Sci; 1988 Aug; 296(2):143-52. PubMed ID: 3041833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for acute myocardial infarction--round 2.
    Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Bode C; Schuler G; Nordt T; Schönermark S; Baumann H; Richardt G; Dietz R; Gurewich V; Kübler W
    Circulation; 1990 Mar; 81(3):907-13. PubMed ID: 2106403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.